1. Home/
  2. Compounds/
  3. navitoclax:sorafenib (1:1 mol/mol)

navitoclax:sorafenib (1:1 mol/mol)


SourcesNames Used
CTRPv2navitoclax:sorafenib (1:1 mol/mol)
PharmacoGx navitoclax:sorafenib (1:1 mol/mol)

Cell lines tested with navitoclax:sorafenib (1:1 mol/mol)

835 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
Download CSV

Tissues tested with navitoclax:sorafenib (1:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2154
central nervous systemCTRPv247
large intestineCTRPv244
upper aerodigestive tractCTRPv232
Download CSV
Download Data as CSV

Top molecular features associated with response to navitoclax:sorafenib (1:1 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA RSAD2 CTRPv2 AAC 6.7e-05 1
mRNA CROT CTRPv2 AAC 7.1e-05 1
mRNA SGCE CTRPv2 AAC -6.9e-05 1
mRNA AC096949.1 CTRPv2 AAC 5.7e-05 1
mRNA SDS CTRPv2 AAC -5.1e-05 1
mRNA ADH7 CTRPv2 AAC -5.1e-05 1
mRNA VPS41 CTRPv2 AAC -5.3e-05 1
mRNA C7orf77 CTRPv2 AAC -3.2e-05 1
mRNA SUMO4 CTRPv2 AAC 3e-05 1
mRNA RWDD1 CTRPv2 AAC 1e-05 1
Download CSV